Allogeneic Stem-Cell Transplantation in Hodgkin Lymphoma; A More Favorable Outcome in Patients With Chemo-Sensitive Disease and With Treosulfan-Based Conditioning

被引：0
|
作者：
Shimoni, Avichai [1 ]
Yerushalmi, Ronit [1 ]
Shem-Tov, Noga [1 ]
Volchek, Yulia [1 ]
Avigdor, Abraham [1 ]
Nagler, Arnon [1 ]
机构：
[1] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2012.11.305
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
253
引用
收藏
页码：S239 / S239
页数：1
相关论文
共 50 条
  • [41] FAVORABLE OUTCOME FOR PATIENTS WITH LYMPHOID MALIGNANCIES FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION USING FLUDARABINE TREOSULFAN, COMPARED WITH OTHER REDUCED INTENSITY CONDITIONING REGIMENS
    Yerushalmi, R.
    Shem-Tov, N.
    Volchek, Y.
    Danylesko, I.
    Avigdor, A.
    Nagler, A.
    Shimoni, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S175 - S175
  • [42] Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Hematologic Malignancies After Dose-Escalated Treosulfan/Fludarabine Conditioning
    Casper, Jochen
    Wolff, Daniel
    Knauf, Wolfgang
    Blau, Igor W.
    Ruutu, Tapani
    Volin, Liisa
    Wandt, Hannes
    Schaefer-Eckart, Kerstin
    Holowiecki, Jerzy
    Giebel, Sebastian
    Aschan, Johan
    Zander, Axel R.
    Kroeger, Nicolaus
    Hilgendorf, Inken
    Baumgart, Joachim
    Mylius, Heidrun A.
    Pichlmeier, Uwe
    Freund, Mathias
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3344 - 3351
  • [43] Fludarabine and Treosulfan Conditioning for Allogeneic Stem-Cell Transplantation; a Dose-Intense Regimen with Limited Toxicity
    Shimoni, Avichai
    Rand, Avital
    Shem-Tov, Noga
    Hardan, Izhar
    Volchek, Yulia
    Yerushalmi, Ronit
    Nagler, Arnon
    BLOOD, 2010, 116 (21) : 1427 - 1427
  • [44] Reduced-intensity conditioning for allogeneic stem-cell transplantation (SCT) with fludarabine and intravenous busulfan is associated with improved toxicity profile and longer survival than conditioning with fludarabine and melphalan in patients with chemo-sensitive hematological malignancies
    Shimoni, Avichai
    Hardan, Izhar
    Rand, Avital
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Nagler, Arnon
    BLOOD, 2007, 110 (11) : 596A - 596A
  • [45] Second Haploidentical Hematopoietic Stem Cell Transplantation with Treosulfan-based Conditioning Regimen for Acute Leukemia in Relapse
    Peccatori, J.
    Crucitti, L.
    Greco, R.
    Stanghellini, M. T. Lupo
    Vago, L.
    Cieri, N.
    Giglio, F.
    Morelli, M.
    Assanelli, A.
    Marcatti, M.
    Carrabba, M.
    Marktel, S.
    Perini, T.
    Lorentino, F.
    Girlanda, S.
    Corti, C.
    Bernardi, M.
    Ciceri, F.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S269 - S269
  • [46] Favorable Outcome in Patients with Lymphoid Malignancies Following Allogeneic Stem Cell Transplantation Using Fludarabine and Treosulfan As the Preparative Regimen
    Yerushalmi, Ronit
    Shimoni, Avichai
    Shem-Tov, Noga
    Volchek, Yulia
    Avigdor, Abraham
    Nagler, Arnon
    BLOOD, 2012, 120 (21)
  • [47] Ibritumomab tiuxetan (Zevalin) in the conditioning regimen for autologous and reduced-intensity allogeneic stem-cell transplantation (SCT) in patients with chemo-refractory now Hodgkin's lymphoma
    Shimoni, A
    Zwass, T
    Oksman, Y
    Hardan, L
    Shem-Tov, N
    Yershalmi, R
    Avigdor, A
    Ben-Bassat, I
    Nagler, A
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 119 - 119
  • [48] Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome; A More Favorable Outcome after Fludarabine and Treosulfan Conditioning. a Survey on Behalf of the Chronic Malignancies Working Party of the EBMT
    Shimoni, Avichai
    Nagler, Arnon
    Iacobelli, Simona
    van Biezen, Anja
    Beelen, Dietrich
    Mufti, Ghulam J.
    Ciceri, Fabio
    Kanz, Lothar
    Volin, Liisa
    Richard, Carlos
    Blaise, Didier
    Ganser, Arnold
    Luft, Thomas
    Chevallier, Patrice
    Schwerdtfeger, Rainer
    de Witte, Theo
    Robin, Marie
    Koerger, Nicolaus
    BLOOD, 2014, 124 (21)
  • [49] Pre-Transplantation FDG-PET Predicts Early but Not Late Survival Outcomes Following Allogeneic Transplantation in Chemo-Sensitive Hodgkin Lymphoma
    Reyal, Yasmin
    Kayani, Irfan
    Chakraverty, Ronjon
    Bloor, Adrian
    Fox, Christopher P.
    Thomson, Kirsty
    Fielding, Adele K.
    Taylor, Ben
    Bishton, Mark
    Morris, Emma
    Russell, Nigel
    Mackinnon, Stephen
    Peggs, Karl S.
    BLOOD, 2014, 124 (21)
  • [50] Feasibility of reduced toxicity treosulfan based conditioning for second allogeneic stem cell transplantation
    Radocha, J.
    Zavrelova, A.
    Lanska, M.
    Visek, B.
    Zak, P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S592 - S592
12345